» Articles » PMID: 38931288

Bioactive Compounds in Peel Are Potential Candidates for Alleviating Physical Fatigue Through a Triad Approach of Network Pharmacology, Molecular Docking, and Molecular Dynamics Modeling

Overview
Journal Nutrients
Date 2024 Jun 27
PMID 38931288
Authors
Affiliations
Soon will be listed here.
Abstract

Physical fatigue (peripheral fatigue), which affects a considerable portion of the world population, is a decline in the ability of muscle fibers to contract effectively due to alterations in the regulatory processes of muscle action potentials. However, it lacks an efficacious therapeutic intervention. The present study explored bioactive compounds and the mechanism of action of peel (CR-P) in treating physical fatigue by utilizing network pharmacology (NP), molecular docking, and simulation-based molecular dynamics (MD). The bioactive ingredients of CR-P and prospective targets of CR-P and physical fatigue were obtained from various databases. A PPI network was generated by the STRING database, while the key overlapping targets were analyzed for enrichment by adopting KEGG and GO. The binding affinities of bioactive ingredients to the hub targets were determined by molecular docking. The results were further validated by MD simulation. Five bioactive compounds were screened, and 56 key overlapping targets were identified for CR-P and physical fatigue, whereas the hub targets with a greater degree in the PPI network were AKT1, TP53, STAT3, MTOR, KRAS, HRAS, JAK2, IL6, EGFR, and ESR1. The findings of the enrichment analysis indicated significant enrichment of the targets in three key signaling pathways, namely PI3K-AKT, MAPK, and JAK-STAT. The molecular docking and MD simulation results revealed that the bioactive compounds of CR-P exhibit a stronger affinity for interacting with the hub targets. The present work suggests that bioactive compounds of CR-P, specifically Hesperetin and Sitosterol, may ameliorate physical fatigue via the PI3K-AKT signaling pathway by targeting AKT1, KRAS, and MTOR proteins.

Citing Articles

Insights into the Therapeutic Potential of Active Ingredients of in Combatting Sarcopenia: An In Silico Approach.

Ullah A, Bo Y, Li J, Li J, Khatun P, Lyu Q Int J Mol Sci. 2024; 25(21).

PMID: 39519004 PMC: 11546236. DOI: 10.3390/ijms252111451.

References
1.
Wang M, Liu F, Yao Y, Zhang Q, Lu Z, Zhang R . Corrigendum to "Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats" [J. Ethnopharmacol. 270 (2021) 113816]. J Ethnopharmacol. 2022; 303:115976. DOI: 10.1016/j.jep.2022.115976. View

2.
Hu M, Han M, Zhang H, Li Z, Xu K, Kang H . Curcumin (CUMINUP60®) mitigates exercise fatigue through regulating PI3K/Akt/AMPK/mTOR pathway in mice. Aging (Albany NY). 2023; 15(6):2308-2320. PMC: 10085593. DOI: 10.18632/aging.204614. View

3.
Maier J, Martinez C, Kasavajhala K, Wickstrom L, Hauser K, Simmerling C . ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput. 2015; 11(8):3696-713. PMC: 4821407. DOI: 10.1021/acs.jctc.5b00255. View

4.
Cui Y, Mi J, Feng Y, Li L, Wang Y, Hu J . [ decoction for treating cancer-related fatigue in breast cancer patients: a randomized trial and network pharmacology study]. Nan Fang Yi Ke Da Xue Xue Bao. 2022; 42(5):649-657. PMC: 9178628. DOI: 10.12122/j.issn.1673-4254.2022.05.04. View

5.
Larini L, Mannella R, Leporini D . Langevin stabilization of molecular-dynamics simulations of polymers by means of quasisymplectic algorithms. J Chem Phys. 2007; 126(10):104101. DOI: 10.1063/1.2464095. View